CorWave Presents an Unprecedented Chronic In Vivo Study at the 41st Annual Meeting of the International Society of Heart and Lung Transplantation

By stepworks_adminApril 27, 2021November 6th, 2024Healthcare

No Comments

CorWave Presents an Unprecedented Chronic In Vivo Study at the 41st Annual Meeting of the International Society of Heart and Lung Transplantation

https://www.corwave.com/wp-content/uploads/2021/04/20210427_CorWave_PR_ISHLT.pdf

Tags:

Healthcare CorWave

Previous PostPublication of 1-year Outcomes from PROMISE I of LIMFLOW System Demonstrates Excellent Sustained AFS and Wound Healing in No-option CLTI Patients
Next PostLimFlow Receives Japan PMDA Approval for Clinical Study of Minimally Invasive Technology Designed to Prevent Amputations in CLTI Patients